Effect of siRNA targeting centromere protein-A gene on biological behavior of HepG2 cells.
- Author:
Yong-mei LI
1
;
Zhi ZHU
;
Ying CHEN
;
Zhi-gang LUO
;
Min SHI
;
Ming-hua ZHU
Author Information
- Publication Type:Journal Article
- MeSH: Autoantigens; drug effects; genetics; Carcinoma, Hepatocellular; pathology; Cell Line, Tumor; Centromere Protein A; Chromosomal Proteins, Non-Histone; drug effects; genetics; Gene Expression Regulation, Neoplastic; drug effects; Hep G2 Cells; Humans; RNA Interference; drug effects; RNA, Small Interfering; drug effects; pharmacology; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured
- From: Chinese Journal of Pathology 2008;37(2):124-128
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the influence of siRNA inhibition of CENP-A expression on the biological behavior of HepG2 cells.
METHODSThree pairs of 21 bp reverse repeated motifs of CENP-A target sequence with 9 spacer were synthesized and inserted into vector pSilencer 2.1-U6 neo to generate siRNA eukaryotic expression plasmids. After stable transfection into HepG2 cells, cell growth, apoptosis, cell cycles and plate clone forming efficiency were investigated. Expressions of CENP-A mRNA was monitored by the reverse transcriptase polymerase chain reaction (RT-PCR). The protein expression of CENP-A, bcl-2, Bax, p53, p21waf1 and mdm2 were detected by Western-blotting.
RESULTSTwo eukaryotic expression plasmids with significant siRNA specific inhibition to the CENP-A gene were created. Compared with control cells, HepG2 cells transfected with the constructs showed G1 phase delay (P < 0.01) and cell number decrease in the S phase (P < 0.001), along with an increased apoptotic rate (P = 0.003), significant increase of Bax expression and decreased bcl-2 expression (P< or =0.001). The protein expressions of p21waf1 was higher and mdm2 was lower than those of the control groups. However, the wild type p53 protein expression was not effected by CENP-A siRNA.
CONCLUSIONSAn altered expression of CENP-A may be related to the proliferation of hepatocellular carcinoma through cell cycle regulation involving an altered bcl-2/Bax expression, that may be p53 independent.